chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Took first dose on March 6th 2021 and after that tested Positive for Covid; Took first dose on 06Mar2021 and after that tested Positive for Covid; This is a spontaneous report from a Pfizer- sponsored program. A contactable consumer (patient's daughter) reported that a female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route of administration (lot number unknown) on 06Mar2021 at single dose for COVID-19 immunization. Patient medical history and concomitant medication were not reported. The reporter stated that her mother (patient) took the first dose on 06Mar2021 and after that on unspecified date in 2021, patient tested positive for COVID-19. Patient received a course of treatment for the event.  Reporter was unsure for the lot number (unsure if it is EM9810 or EM4810). Reporter was asking the specific date that her Mom can receive the second dose. Outcome of the event was unknown.
She did not get a reaction other than a sore arm with the first one; This is a spontaneous report from a Pfizer Sponsored Program  Support. A contactable 70-year-old female consumer (patient) reported for herself that: A 70-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot Number: Unknown), via an unspecified route of administration, on 19Jan2021 (at the age of 70-year-old), as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On unspecified date in 2021, the patient experienced did not get a reaction other than a sore arm with the first dose. Patient has antibodies found in body and asked if patient can take third dose even though still has the antibodies. Patient reported that will see doctor on 01Oct2021 and wanted to see second blood test to see if patient still high in antibodies. Patient's antibodies went from 1287 to now 1171 and known people with Covid who have less antibodies and warn that still if patient can catch the virus. patient has seen other people who have had reactions after the 3rd dose and did not have any information to provide on any of those people. Patient did not want to get sick, and patient reported that did not get a reaction other than a sore arm with the first dose of vaccination. Patient already spoken with someone earlier and received a questionnaire in the mail and never returned it. Patient did not want to provide a complete report at this time and did not have a reference number for previous report and said it was a few months ago and forgot it. Patient received Pfizer COVID Vaccine was 19Jan2021 and did not have the lot or expiration for the first dose and it not written on the card. The second dose was given 09Feb2021 with Lot EM9810 expiration is unknown. Patient reported that on 09Oct2021, it will be 8 months in, and it was just approved to have booster 6 months in and received the vaccines. On unspecified date in 2021 the patient underwent lab tests and procedures which included antibody test: unknown results and antibodies went from 1287 to now 1171, on 2021 blood test: unknown results. The clinical outcome of event was unknown.    Information about lot/batch has been requested.
This spontaneous report as received from a pharmacist refers to her husband, 61 year old male patient. The patient's concurrent condition includes gout. The patient's medical history included skin dryness or itching on legs and dandruff problem on scalp. The patient did not have any past drug reactions or allergies. On 02-OCT-2014, the patient was vaccinated with ZOSTAVAX lot # K008884, expiration date 20-SEP-2015, 0.65 ml, subcutaneously. Concomitant therapies included colchicine, indomethacin (manufacturer unknown), probiotics (unspecified) and niacinamide. On 03-OCT-2014, the patient developed a red, warm blister at the ZOSTAVAX injection site which resolved approximately on 10-OCT-2014 (reported as after about one week). In October 2014 (reported as one to three weeks after the administration of ZOSTAVAX), the patient developed tiny, little blister things on his face, near his eyes, on his forehead and on his scalp which were all painful at times. On an unknown date, the patient also experienced dry, flaky skin on his face and itching on his face and scalp. On an unknown date, the patient's eyes were red and puffy. All these events would appear, go away and then reappear at unspecified intervals. On an unknown date, the patient sought medical attention at the office of unspecified physician. No treatment was reported. No lab diagnostic studies were performed. The outcome of the events of "red, warm blister at the ZOSTAVAX injection site" was reported as recovered/resolved. The outcome of the other events was unknown. The relatedness between the event and the vaccination with ZOSTAVAX was not provided. Additional information has been requested.
sick; Initial information was received on 13-Nov-2020 regarding an unsolicited valid non-serious social media case from a consumer via Social media.  This case involves a patient (unknown demography) who got sick (illness), while the patient received INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient got sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Patient developed redness and significant swelling at the site of reaction followed by swelling that spread down the arm to the hand and lasted for 2 to 3 days.
Patient presented to pharmacy with red blotchy hive looking appearance near the vaccination site. Patient was advised to contact their medical provider. Provider advised patient to take benedryl, which the patient did and noticed a decrease in redness.
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting,  back and neck pain, leg cramping, mild fatigue, left arm pain   Narrative:
Information has been received from a licensed visiting nurse concerning an unspecified number of females (ages unknown), who, on unspecified dates, were vaccinated with doses of GARDASIL. It was reported that "alot of girls are fainting (10%) and complaining that the injection was very painful (100%)." The fainting occurred when the patients were in the waiting room or getting ready to got to the waiting room. At the time of the report, the outcome of the patients were unknown. No product quality complaint was involved. Follow-up information indicated that the n nurse had not kept a record of the specific patients that had experienced these symptoms. It was reported that the nurse felt that the symptoms were common in patients who were receiving multiple vaccinations at the same visit. It was reported that the patients would become panic stricken with the anticipation of multiple injections. Due to the fact that no records of these incidences had been kept, no additional patient details could be provided. This is one of two reports from the same source. Additional information is not expected.
Arm was sore all the time. Chills started in middle of night and kept patient awake.  Today in the morning, patient has body aches and feels tired--has no energy at all.    Patient feels nauseous and can't eat anything. Chills continue.    Patient contacted doctor but was told they were expected symptoms. Patient took Ibuprofen last night and in the morning but did not help much.  Patient continues to drink liquids.  Patient specifies nose is very dry.   Patient received Flu vaccine from same facility.
The day after receiving 1st dose, he noticed that his back started hurting.; He hasn't been doing any physical exercise which he had been doing in past because of back pain that started after receiving 1st dose; He feels very limited doing physical activity because of back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (The day after receiving 1st dose, he noticed that his back started hurting.), EXERCISE TOLERANCE DECREASED (He hasn't been doing any physical exercise which he had been doing in past because of back pain that started after receiving 1st dose) and MOBILITY DECREASED (He feels very limited doing physical activity because of back pain) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In July 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced BACK PAIN (The day after receiving 1st dose, he noticed that his back started hurting.), EXERCISE TOLERANCE DECREASED (He hasn't been doing any physical exercise which he had been doing in past because of back pain that started after receiving 1st dose) and MOBILITY DECREASED (He feels very limited doing physical activity because of back pain). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, BACK PAIN (The day after receiving 1st dose, he noticed that his back started hurting.), EXERCISE TOLERANCE DECREASED (He hasn't been doing any physical exercise which he had been doing in past because of back pain that started after receiving 1st dose) and MOBILITY DECREASED (He feels very limited doing physical activity because of back pain) outcome was unknown.            No concomitant medication provided. The day after receiving 1st dose, patient started to  hurt his back. Patient took 2nd dose on 10Aug2021 on his right arm.
edema in rt upper extremity (described by mom as twice its nl size by 7PM, 8 1/2hr p/vax given);pt arm still swollen above & below shot site w/redness & is hot to touch;shot area has edema w/o redness or heat;
Second dose (bivalent) was administered prior to recommended interval of 8 weeks following a monovalent first dose.
Don't think this is reportable, or because of the vaccine, but I have recently been prescribed medication for high blood pressure. The form asked if my health situation has changed since the vaccine and I answered "yes".  Was discovered after regular annual wellness check-up.
Burning in anterior portion of tongue. Observed for 30 minutes and symptoms resolved. no other symptoms.  Able to be released.
SWOLLEN ARM ABOUT 10 INCHES DOWN FROM INJECTION SITE; CHILLS; FEVER 101.5; This spontaneous report received from a patient concerned a 31 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination on Left Arm. No concomitant medications were reported. On 25-MAR-2021, the subject experienced swollen arm about 10 inches down from injection site. On 25-MAR-2021, the subject experienced chills. On 25-MAR-2021, the subject experienced fever 101.5. Laboratory data included: Body temperature (NR: not provided) 101.5 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, fever 101.5, and swollen arm about 10 inches down from injection site. This report was non-serious.; Sender's Comments: V0: Medical assessment comments not required as per the standard procedure as the case is assessed as non-serious
Patient reports feeling increased mucous production and "throat swelling" about 10 minutes after vaccine, Patient had a known allergy and brought Benadryl, Zantac and epi to the clinic.  She self administered 50mg of Benadryl and a Zantac. She declined Epi administration and did not feel like her throat was closing, denies shortness of breath, she is not in distress.  O2 sats remained of 98%, she was monitored for 30 minutes with no progression of her symptoms and felt better at the time she left the clinic, she called her PCP and headed to them for a Medrol injection
affected my brain - recall; cognitive skulls; Felt little groggy; It was like moving may be like a size of a pea or something like that I could feel it moving; A pain went up from where the injection was up my arm thought my shoulder up my neck and up to my brain; A pain went up from where the injection was up my arm thought my shoulder up my neck and up to my brain; A pain went up from where the injection was up my arm thought my shoulder up my neck and up to my brain; A pain went up from where the injection was up my arm thought my shoulder up my neck and up to my brain; A pain went up from where the injection was up my arm thought my shoulder up my neck and up to my brain; The initial case was missing the following minimum criteria: suspect product was not reported or specified. Upon receipt of follow-up information on  02Aug2021, where the case becomes valid, this case nowcontains all required information to be considered valid.  This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received BNT162B2 (Lot Number: ER8737), via an unspecified route of administration on 03Mar2021 (at the age of 70-years old), in left arm, as dose 1, single for COVID-19 immunization. Patient's medical history and concomitant medications were reported as none. At the time of reporting, patient haven't received the 2nd shot. It was reported that on 03Mar2021, after received the Pfizer shot, patient didn't had any problem, but later, after 20 mins, when she get back home she felt little groggy, so she laid down and when she was lying down, a pain went up from the injection site, up her arm, from the shoulder where the injection was, to the neck and up to her brain. Patient reported that it wasn't a pain, it was like a pea or a marble something like that she could feel it like moving from the site, from the shoulder to the neck all the way to her head. Also reported that on an unspecified date at 11:00, her brain recall and cognitive skulls got affected.  After that episode she didn't had any more problem. She was able to go for her regular duties and she is fine now. No culture was performed.  No treatment was given for the events and also events not resulted in hospital admission. The outcome of the events affected my brain-recall and cognitive skulls was unknown and of all other events was recovered.
Information of prospective pregnancy report has received from a nurse referring to a female patient of unknown age. On 27-JAN-2016 the patient was inadvertently vaccinated with a dose of VARIVAX (Merck) (lot# L037562, expiration 29-SEP-2017, dose, frequency and route were not reported) (vaccine exposure during pregnancy). The patient was unaware of pregnancy at time of administration; patient took a home pregnancy test which came up positive on 31-JAN-2016. Patient's last menstrual period (LMP) was 22-DEC-2015 and estimated due date (EDD) of 27-SEP-2016. No adverse effect was reported. The pregnancy outcome was outcome pending. Additional information has been requested.
Arm out of commission for a couple of weeks; This case was reported by a consumer via interactive digital media and described the occurrence of arm discomfort in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (Family History) (patient's brother had shingles years ago).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced arm discomfort. On an unknown date, the outcome of the arm discomfort was recovered/resolved.   It was unknown if the reporter considered the arm discomfort to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR131239   Additional Information: GSK Receipt Date: 10-SEP-2022 Reporter's Comments: This case was received from consumer via interactive digital media. The reporter though the after first shot his/her arm was pretty much out of commission for a couple of weeks but at least now hopefully patient was covered. The follow-up could not be possible as no contact details were available. The case had been linked with US2022AMR131239 reported by same reporter for same patient.; Sender's Comments:  US-GSK-US2022AMR131239:Same reporter.
Headache; Naseua; Pain at shot location; Was very white no color at all; Feel bad; This case was reported by a consumer and described the occurrence of headache in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd October 2019, the patient received the 2nd dose of Shingrix. In October 2019, less than a week after receiving Shingrix, the patient experienced headache, nausea, injection site pain, skin discoloration and feeling bad. On an unknown date, the outcome of the headache, nausea, injection site pain, skin discoloration and feeling bad were not recovered/not resolved.   It was unknown if the reporter considered the headache, nausea, injection site pain, skin discoloration and feeling bad to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the upper left deltoid. The reporter stated that, the day before reporting, the patient received dose of Shingrix and experienced headache, naseua a lot of pain at shot location. The reporter stated that, the patient was going back to the bed and was tough, so he would see how the patient rebounds, In no improvement, he would take the patient to the primary care. The reporter stated that, when the patient came out of the bedroom, was very white no color at all. The reporter stated that, the patient received 1st and 2nd dose at pharmacy. The reporter consented to follow up with physician.
So I had a blood clot that happened around 8/3/2021, I was prescribed blood thinners - Lovanox and I am supposed to be on it for a course of maybe three months; and that is basically it.
12/15/08--Patient received Td on 9/26/2008 and started having soreness at beginning of November/08--started having upper arm, neck pain (left side) when moving arm in full range of motion.  Has pain of 9.5 on scale of 1-10.  Pain is in left arm.  1/7/09--followup with patient.  Pt states the pain still comes and goes, still has full range of movement.  The pain seems to be better, but still can't go all day without hurting.
Injection site erythema, induration, pain with hive like rash running to inside arm and down arm; fever, chills, headache.
No reaction for first twelve hours after vaccination but then all these side effects for the next two days: Swollen and very sore lymph node in right armpit -- the same arm in which I received the shot Nausea Fever (100.6 degrees) and chills Joint aches and muscle pains Headache Fatigue Soreness at site of injection
Localized reaction at injection site with swelling, redness, warmth and nodule. This resolved without treatment in 5 days. Also, complained of stomachache, 2 days, post vax, which resolved in 2 days.
Coughing, hoarseness, swelling of my throat (difficulty swallowing), painful itchy red eyes, weeping of my eyes and nose, bloodshot eyes, severe chills and aches of my body, severe headache, high fever (102.2 while on ibuprofen).
Saw rheumatologist 10/14/2010 and he said I had cellulitis. Put me on an antibiotic. Told me to see my primary car physician within 48 hours.
muscle pain under her rib cage and sides; Chills; This is a spontaneous case received from a contactable female consumer(patient) A 63-year-old female patient received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number unknown, Expiration Date: unknown), via an unspecified route of administration for COVID-19 immunization. On 16-MAR-2021 at single dose for Covid-19 immunization. The patient medical history and concomitant medications were not reported. On 19 MAR 2021 patient experienced muscle pain under her rib cage and sides and chills. The caller would like to know if this is normal to experience these side effects a couple days after receiving the vaccine. How long will the side effects last and what can be done about the side effects. The outcome of event was unknown.   Follow-up attempts are needed. Information on the lot/batch number has been requested.
This case was reported by a pharmacist via sales rep and described the occurrence at injection site wheal in a patient who received FLULAVAL QUADRIVALENT. On an unknown date, the patient received FLULAVAL QUADRIVALENT. On an unknown date, unknown after receiving FLULAVAL QUADRILVANT, the patient experienced injection site wheal, injection site pain and injection site swelling. On an unknown date, the outcome of the injection site wheal, injection site pain and injection site swelling were unknown. It was unknown if the reporter considered the injection site wheal, injection site pain and injection site swelling to be related to FLULAVAL QUADRIVALENT. Additional details were reported as follows: The age at vaccination was not reported. The sales representative believed that the flu vaccine received by the patient was the FLULAVAL QIV Pre Filled Syringe. The patient complained of a 2 inch welt, soreness, and swelling at the injection site. The sales representative had no patient identifiers or lot and expiration date of the vaccine. The health care professional could be contacted directly for further information. This was one of the 5 cases, reported by the same reporter.
Sore arm, neck, back and left side of body. Headache. Extremely tired. Took Advil every four hours and sleep. Felt better after 24 hours. Arm sore for a couple days.
Red, big and swollen on most part of left tricep area, 1/2 inch in thickness, mostly hurting. No other concerns, according to patient's wife. Patient is on travel, will see medical. Patient took no meds.
Sick... very sick; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (Sick... very sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick... very sick). At the time of the report, ILLNESS (Sick.. very sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
after 48 hours became very weak and fatigued.  Became worse through the month of February.  Had 2 doctor visits, blood tests, shot of steroids, prescription of steroids. 2 ER visits, 4 day hospitalization Low Cortisol now and have to see Endocrinologist missed lots of work and still cannot work my full 6 hours of work.
Broke out in rash over most of body 1-24-06 thru 1-25-06. Diagnosed with chicken pox by the CFNP. 1-25-06 Pt received varicella vaccine 11-15-1996
This spontaneous report as received from a medical assistant (also reported as administrator) refers to a patient of unknown age and gender. On 04-JUN-2016, unspecified dose of improperly stored VARIVAX (lot # 1041204, expiry date: 20-OCT-2017 or 1048466, expiry date: 02-DEC-2017 or M000761, expiry date 16-JAN-2018) was administered to the patient (incorrect product storage). No adverse events were reported. The outcome was unknown. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.